Foreign Experience of Legal Regulation of Names of Biomedical Cell Products

This article examines foreign and international experience in formulating the names of biomedical cell products and their various types. The relevance of the topic of this study is concerned with the practice of developing and subsequent registration of BMCP is just emerging in the Russian Federation, however, the use of international experience in the names of finished drugs is important for the subsequent certification and circulation of such products on the market. The purpose of the study is to consider foreign and international practice and standards in the formulation of the names of BMCP. Research methodology: analysis of the practice of naming biomedical cell products at the international level and abroad. The novelty of the research lies in the consideration of the foreign experience of BMCP names and the formulation of proposals for the introduction of international practice into Russian legislation.

biomedical cell products (BMCP), international non-proprietary name, infix, affix (prefix, suffix), cell therapy products